Yan, J., Zhao, Q., Gabrusiewicz, K., Kong, L., Xia, X., Wang, J., . . . Li, S. (2019). FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation. Nature communications, 10(1), 448-15. https://doi.org/10.1038/s41467-018-08271-x
Chicago Style (17th ed.) CitationYan, Jun, et al. "FGL2 Promotes Tumor Progression in the CNS by Suppressing CD103+ Dendritic Cell Differentiation." Nature Communications 10, no. 1 (2019): 448-15. https://doi.org/10.1038/s41467-018-08271-x.
MLA (9th ed.) CitationYan, Jun, et al. "FGL2 Promotes Tumor Progression in the CNS by Suppressing CD103+ Dendritic Cell Differentiation." Nature Communications, vol. 10, no. 1, 2019, pp. 448-15, https://doi.org/10.1038/s41467-018-08271-x.
Warning: These citations may not always be 100% accurate.